Theranostic perspectives of [67Ga/111In/177Lu]NeoBOMB1 in prostate cancer - First evidence for clinical translation with [68Ga]NeoBOMB1 and PET/CT

被引：0
|
作者：
Nock, B. A. [1 ]
Maina-Nock, T. [1 ]
Kaloudi, A. [1 ]
Giarika, A. [1 ]
Lymperis, E. [1 ]
Singh, A. [2 ]
Kulkarni, H. R. [2 ]
Klette, I. [2 ]
Krenning, E. P. [3 ]
de Jong, M. [3 ]
Baum, R. P. [2 ]
机构：
[1] NCSR Demokritos, Mol Radiopharm, INRASTES, Athens, Greece
[2] Zentralklinik, Theranost Ctr Mol Radiotherapy Mol Imaging, Bad Berka, Germany
[3] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP149
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 32 条
  • [1] [68Ga]NeoBomb1, a new potent GRPR-antagonist for PET imaging - Preclinical and first clinical evaluation in prostate cancer
    Nock, Berthold
    Kaloudi, Aikaterini
    Lymperis, Emmanouil
    Giarika, Athina
    Bergsma, Hendrik
    Mueller, Dirk
    Krenning, Eric
    de Jong, Marion
    Maina, Theodosia
    Baum, Richard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [2] NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice
    Kaloudi, Aikaterini
    Lymperis, Emmanouil
    Giarika, Athina
    Dalm, Simone
    Orlandi, Francesca
    Barbato, Donato
    Tedesco, Mattia
    Maina, Theodosia
    de Jong, Marion
    Nock, Berthold A.
    [J]. MOLECULES, 2017, 22 (11):
  • [3] 68Ga/177Lu-NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use
    Dalm, Simone
    Bakker, Ingrid
    de Blois, Erik
    Doeswijk, Gabriela
    Konijnenberg, Mark
    Orlandi, Francesca
    Barbato, Donato
    Tedesco, Mattia
    Maina, Theodosia
    Nock, Berthold
    de Jong, Marion
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [4] Theranostic Perspectives in Prostate Cancer with the Gastrin Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
    Nock, Berthold A.
    Kaloudi, Aikaterini
    Lymperis, Emmanouil
    Giarika, Athina
    Kulkarni, Harshad R.
    Klette, Ingo
    Singh, Aviral
    Krenning, Eric P.
    de Jong, Marion
    Maina, Theodosia
    Baum, Richard P.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (01) : 75 - 80
  • [5] [68Ga] NeoBOMB1, a new candidate in the diagnosis of breast cancer: First results in GRPR-expressing cells and animal models
    Maina-Nock, T.
    Kaloudi, A.
    Giarika, A.
    Lymperis, E.
    Dalm, S. U.
    Orlandi, F.
    Barbato, D.
    Tedesco, M.
    de Jong, M.
    Nock, B. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S104 - S105
  • [6] 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology
    Dalm, Simone U.
    Bakker, Ingrid L.
    de Blois, Erik
    Doeswijk, Gabriela N.
    Konijnenberg, Mark W.
    Orlandi, Francesca
    Barbato, Donato
    Tedesco, Mattia
    Maina, Theodosia
    Nock, Berthold A.
    de Jong, Marion
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) : 293 - 299
  • [7] Preliminary diagnostic performance of [68Ga]-NeoBOMB1 in patients with gastrin-releasing peptide receptor-positive breast, prostate, colorectal or lung tumors (NeoFIND)
    Djaileb, Loic
    Morgat, Clement
    van der Veldt, Astrid
    Virgolini, Irene
    Cortes, Frederic
    Demange, Arnaud
    Orlandi, Francesca
    Wegener, Antje
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [8] 68Ga/177Lu-NeoBOMB1, A Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology (vol 58, pg 293, 2017)
    Dalm
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (07) : 1164 - 1164
  • [9] Preclinical imaging and radiotherapy of prostate cancer using the theranostic twins(68Ga/177Lu)-radiolabeled peptides
    Lim, J. C.
    Cho, E. H.
    Lee, S. Y.
    Dho, S. H.
    Kim, S. Y.
    Jung, S. H.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S67 - S68
  • [10] Experimental study of 68Ga/177Lu PSMA I&T: A novel PSMA inhibitor for theranostic of prostate cancer
    Zhang, Lulu
    Zhang, Pengjun
    Wang, Feng
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S528 - S529
1234